期刊
AUTOIMMUNITY REVIEWS
卷 13, 期 6, 页码 655-667出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2013.12.001
关键词
Raynaud's phenomenon; Systemic sclerosis; Connective tissue disease; Autoantibodies; Smooth muscle cells; Targeted therapy
类别
资金
- Italian Group for Systemic Sclerosis (GILS), Milan, Italy
- Italian Group for Systemic Sclerosis (GILS)
Raynaud's phenomenon (RP) is a well defined clinical syndrome characterized by recurrent episodes of digital vasospasm triggered by exposure to physical/chemical or emotional stress. RP has been classified as primary or secondary, depending on whether it occurs as an isolated condition (pRP) or is associated to an underlying disease, mainly a connective tissue disease (CTD-RP). In both cases, it manifests with unique triple (pallor, cyanosis and erythema), or double color changes. pRP is usually a benign condition, while sRP can evolve and be complicated by acral digital ulcers and gangrene, which may require surgical treatment. The pathogenesis of RP has not yet been entirely clarified, nor is it known whether autoantibodies have a role in RP. Even so, recent advances in our understanding of the pathophysiology have highlighted novel potential therapeutic targets. The aim of this review is to discuss the etiology, epidemiology, risk factors, clinical manifestations, recently disclosed pathogenic mechanisms underlying RP and their correlation with the available therapeutic options, focusing primarily on pRP and CTD-RP. (C) 2014 Elsevier S.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据